
    
      This is a multi-center, open label, continuation trial of LymphoStat-Bâ„¢ in Rheumatoid
      Arthritis (RA) subjects who achieved at least an ACR20 response in the Phase 2 study LBRA01
      (NCT00071812).
    
  